Bayer has loans in place for its proposed purchase of Merck & Co.’s consumer care business, according to Bloomberg News.

The $14.2 billion loan package includes a $12.2 billion bridge facility and $2 billion term loan, and involves commitments from 23 banks, Bloomberg reported, citing a statement from BNP Paribas. The French bank coordinated the deal with Bank of America and Mizuho Financial Group.

The German company is buying the Whitehouse Station-based company’s consumer care unit as part of a refocus on brand-name treatments that can be sold directly to consumers, Bloomberg said.

ALSO ON NJBIZ:

Be careful: For legal reasons, ACA-prompted wellness programs must be structured carefully

Top 10 rankings of New Jersey's best places for homeownership

Jersey Shore real estate agencies merge